00069-0308 Trazimera - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

00069-0308

Brand Name:

Trazimera

Generic Name:

trastuzumab-qyyp

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: TRASTUZUMAB

Strength: 150.0

Unit: mg/7.15mL

Packages:

Code: 00069-0308-01

Description: 1 VIAL in 1 CARTON (0069-0308-01) / 7.15 mL in 1 VIAL

Effective Date: March 10, 2021

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use